PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'INSERM UMRS 1148 LVTS and University of Paris, Paris, France.\', \'Gastroenterology Department, Beaujon Hospital, APHP, Clichy, France.\', \'Haematology Department, Beaujon Hospital, APHP, Clichy, France.\', \'Intensive Care Unit, Beaujon Hospital, APHP, Clichy, France.\', \'CRI, INSERM UMRs 1149 and University of Paris, Paris, France.\', \'Biochemistry Department, Beaujon Hospital, APHP, Clichy, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0249799
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33857216
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • I-FABP is decreased in COVID-19 patients, independently of the prognosis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all